07.30 – 08.00 Poster setup, Breakfast

08.15 – 08.30

Opening (Meignan, Gallamini, Haioun)

Imaging in Myeloma

08.30 – 10.30 Chair: Bodere/Zamagni

08.30 – 08.50: New imaging approaches with MRI (Rahmouni )

08.50 – 09.10: Combined MRI and PET (Messiou )

09.10 – 09.30: Prognostic role of FDG-PET in myeloma (Nanni, Zamagni ) 09.30 – 09.50: Response assessment with PET and MRI (Moreau ). 09.50 – 10.05: F-choline (Montravers/Garderet )

Discussion 10.05-10.30

10.00 – 12.00

Coffee break, Poster Viewing and discussion

Cheson/Duhrsen/ Kostakoglu/ Vander Borght

Imaging in lymphoma from 1999 to Lugano: what next?

12.00 – 13.00 Bruce Cheson

Discussion 12.45-13.00

13.00 – 14.00 Lunch

Imaging and T cell lymphoma.

14.00 – 16.00

Chair: Federico/Barrington

14.00 – 14.20: Clinical presentation and new drugs in PTCL (Pro ) 14.20 – 14.40: Prognosis in PTCL (Gallamini )

14.40 – 15.00: PET in PTCL (Cottereau /El Galaly/Hutchings)

15.00 – 15.20: PET in NK/T lymphoma (Kim )

Discussant (all) 15.20-16.00: Ancillary studies and new trials?

16.00 – 16.30 Coffee break

European cooperation in Lymphoma and Joint ICIS/Lymphoma meeting

16.30 –17.00 Zucca/Oyen /Meignan /Rahmouni/Gallamini

PET based response evaluation according to Lugano classification: where we are in daily practice

17.00 –18.00 Chair: Trneny/Ceriani

17.00 – 17.15: Hodgkin Lymphoma (Kobe )

17.15 – 17.25: End treatment PET in DLBCL (Zucca )

17.25 – 17.35: End treatment PET in Follicular Lymphoma (Trotman ) 17.35 – 18.00: Discussant: speakers, Casasnovas , Kluge , Barrington

PET and immunotherapy in lymphoma: how to report?

19.30: Bus departure from the Palais de l’Europe to the Gala dinner